Jane Street
SANA icon

Jane Street’s Sana Biotechnology SANA Stock Holding History

Jane Street’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.8K Buy
+11,400
New +$36.7K ﹤0.01% 11016
2024
Q3 		– Sell
-16,100
Closed -$87.9K – 10306
2024
Q2 		$87.9K Buy
16,100
+600
+4% +$4.78K ﹤0.01% 8778
2024
Q1 		$155K Buy
+15,500
New +$116K ﹤0.01% 8330

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Jane Street's SANA Position: Q2 2026 in Review

Jane Street sold out of Sana Biotechnology (SANA) in Q2 2026, closing a stake of 132,715 shares — an estimated $428K sold.

Jane Street first reported a position in SANA in Q2 2022 and held it in 15 quarters. The position peaked at $2.72M in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Jane Street reported no remaining Sana Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 132,715 Sana Biotechnology shares in Q2 2026, an estimated $428K.
  • Jane Street first reported a position in Sana Biotechnology in Q2 2022 and held it in 15 quarters.
  • Jane Street's Sana Biotechnology position peaked at $2.72M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.